Federated Hermes
RGNX icon

Federated Hermes’s Regenxbio RGNX Stock Holding History

Federated Hermes’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-569
Closed -$4.4K – 2179
2024
Q4 		$4.4K Buy
569
+124
+28% +$1.16K ﹤0.01% 1906
2024
Q3 		$4.67K Buy
+445
New +$5.42K ﹤0.01% 1866
2023
Q3 		– Sell
-2,195
Closed -$43.9K – 2182
2023
Q2 		$43.9K Sell
2,195
-1,921
-47% -$37K ﹤0.01% 1693
2023
Q1 		$77.8K Buy
4,116
+1,031
+33% +$22.8K ﹤0.01% 1699
2022
Q4 		$70K Buy
+3,085
New +$69.7K ﹤0.01% 1672
2018
Q4 		– Sell
-27,200
Closed -$2.05M – 2280
2018
Q3 		$2.05M Buy
27,200
+4,151
+18% +$299K ﹤0.01% 1083
2018
Q2 		$1.65M Buy
+23,049
New +$1.1M ﹤0.01% 1100
2016
Q2 		– Sell
-115,567
Closed -$1.25M – 2165
2016
Q1 		$1.25M Sell
115,567
-59,433
-34% -$761K ﹤0.01% 1021
2015
Q4 		$2.9M Hold
175,000
– – 0.01% 732
2015
Q3 		$3.85M Buy
+175,000
New +$4.47M 0.01% 645

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Federated Hermes's RGNX Position: Q1 2025 in Review

Federated Hermes sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 569 shares — an estimated $4.4K sold.

Federated Hermes first reported a position in RGNX in Q3 2015 and held it in 10 quarters. The position peaked at $3.85M in Q3 2015. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Federated Hermes reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 569 Regenxbio shares in Q1 2025, an estimated $4.4K.
  • Federated Hermes first reported a position in Regenxbio in Q3 2015 and held it in 10 quarters.
  • Federated Hermes's Regenxbio position peaked at $3.85M in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.